Access Holdings Plc and Coronation Group hosted a private reception at London’s Tate Modern to mark the international impact ...

Board of Directors has resolved to launch a new stock option program for Nightingale Health’s or its group companies’ employees or other key persons. The purpose of Nightingale Health’s stock option ...

Verici Dx plc (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, today announced it has received clinical laboratory accreditation from the New York State Department of ...

Access Holdings Plc and Coro­nation Group hosted a private reception at Tate Modern, London, to celebrate the en­during legacy of Nigerian Modernism, one of the most significant presentations of ...

Good morning, and thank you for joining us. I'm Tamsin, and I'm here with my colleagues, Jonathan Maxwell, Eugene Kinghorn, Ben Griffiths. Today, we're presenting the results for the year ended 31st ...

DNA Damage Response (“DDR”) inhibitors, a category of drugs that work by blocking cancer cells' capacity to fix their own damaged DNA, are growing well beyond the poly ADP ribose polymerase (“PARP”) ...

Capella Minerals Ltd. (FRA: N7D) ("Capella" or the "Company") is pleased to report results from a maiden diamond drill program completed recently at the Killero E copper-gold project in the Central ...

How smarter, more user-focused display technology can better support work and play.

The City watchdog has warned motor finance lenders it is “very concerned” with how prepared the industry is to implement its ...

Despite C-suite optimism and more investment, there's a big gap between AI aspirations and enterprise readiness. The answer?

It’s an explanation that sounds remarkably similar to the problems besetting Williams, where embattled boss James Vowles says ...

A new generation of drugs could ‘switch off’ asthma, effectively curing it. That would mean no more puffers and no more flare ...